Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesGenetic & Molecular TestingAetna Genetic Counseling Coverage Policy Update | …
    Ask Trek AI about this page
    CurrentAetnaPolicy 0189

    Genetic Counseling

    Customize your policy alerts

    Sign up for Aetna Policy 0189 alerts

    Get alerted when Policy 0189 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs when genetic counseling is considered medically necessary for Aetna members, primarily in pregnancy management and in conjunction with medically necessary genetic testing, and identifies indications considered experimental or investigational.

    Policy Summary
    PayerAetna
    PolicyGenetic Counseling
    Policy CodePolicy 0189
    Change TypeNo material change
    Effective DateNov 19, 1997
    Last ReviewMar 28, 2023
    Next Review DateFeb 8, 2024
    Key ActionObtain informed consent and document counseling per ACMG guidance when genetic counseling accompanies testing.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    13+listed pregnancy indications

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    96040, S0265
    codes referenced
    03/28/2023last review
    02/08/2024next review

    Coverage Criteria for Genetic Counseling

    Genetic counseling — pregnancy management (Medically Necessary)

    Covered when ANY ONE of the following pregnancy-related indications is present:

    Pregnancy management indications: 1. Couples who are closely related genetically (consanguinity, incest); 2. Familial cancer disorders; 3. Individuals from ethnic groups recognized to be at increased risk for specific genetic disorders (e.g., African Americans for sickle cell anemia, Ashkenazi Jews for Tay-Sachs disease); 4. Infertility cases where either parent is known to have a chromosomal abnormality; 5. Individuals with primary amenorrhea, azoospermia, abnormal sexual development or failure in developing secondary sexual characteristics; 6. Mother known or presumed carrier of an X-linked recessive disorder; 7. One or both parents are known carriers of an autosomal recessive disorder; 8. Parents of a child born with a genetic disorder, birth defect, inborn error of metabolism or chromosome abnormality; 9. Parents of a child with autism, developmental delays, intellectual or learning disabilities; 10. Pregnant women who, based on prenatal ultrasound tests or an abnormal multiple marker screening test, maternal serum alpha-fetoprotein (AFP) test, test for sickle cell anemia, or tests for other genetic abnormalities have been told their pregnancy may be at increased risk for complications or birth defects; 11. Pregnant women with maternal age 35 years or greater at delivery; 12. Pregnant women, or women planning pregnancy, exposed to potentially teratogenic, mutagenic or carcinogenic agents (chemicals, drugs, infections, radiation); 13. Previous unexplained stillbirth or repeated (3 or more; 2 or more among infertile couples) first trimester miscarriages where there is suspicion of parental or fetal chromosome abnormalities; 14. When contemplating pregnancy, either parent affected with an autosomal dominant disorder.

    Any single listed indication qualifies (policy uses OR logic).

    Genetic counseling — non-pregnancy (Medically Necessary)

    Covered when provided in consideration of, or in conjunction with, medically necessary genetic testing and consistent with ACMG guidelines.

    Counseling tied to testing: Genetic counseling unrelated to pregnancy is medically necessary when it is provided in consideration of, or in conjunction with, medically necessary genetic testing, and is in accordance with the American College of Medical Genetics (ACMG) guidelines.

    Both conditions must be met.

    Experimental and Investigational (Not Covered)

    Not covered when the indication is not among the listed ones:

    Other indications: Genetic counseling is considered experimental and investigational for all other indications because its effectiveness for indications other than those listed has not been established.

    Services for indications not listed in the medical necessity section are not covered.

    Genetic counseling services provided for pregnancy management may not be covered if the member's benefit plan explicitly excludes family planning benefits. Providers should verify the member's specific benefit plan description before billing or scheduling services, as coverage for pregnancy-related counseling is dependent on plan provisions.

    Genetic counseling for indications that are not listed in the policy is considered experimental and investigational and therefore not medically necessary. Coverage is limited to the specified indications; services for other reasons may be denied because effectiveness for those indications has not been established.

    Specific Indications and Scenarios

    Pregnancy-related risk factors and scenarios listed in the policy

    Listed pregnancy-related risk factors and scenarios: Consanguinity (incest); familial cancer disorders; membership in ethnic groups at increased risk for specific genetic disorders (e.g., African Americans for sickle cell anemia, Ashkenazi Jews for Tay-Sachs); parental carrier status for autosomal recessive disorders; infertility with a parental chromosomal abnormality; primary amenorrhea, azoospermia, abnormal sexual development or failure to develop secondary sexual characteristics; mother known or presumed carrier of an X-linked recessive disorder; parents of a child with a genetic disorder, birth defect, inborn error of metabolism, or chromosome abnormality; parents of a child with autism, developmental delays, intellectual or learning disabilities; abnormal prenatal screening/ultrasound/multiple marker screening/AFP or other tests indicating increased risk; maternal age >= 35 years at delivery; exposure to potentially teratogenic, mutagenic or carcinogenic agents; previous unexplained stillbirth or repeated first trimester miscarriages (3 or more; 2 or more among infertile couples); either parent affected with an autosomal dominant disorder when contemplating pregnancy.

    Each item alone qualifies under the pregnancy management criteria.

    Genetic counseling in conjunction with medically necessary genetic testing per ACMG guidelines

    Counseling with medically necessary testing:

    Billing and Diagnosis Codes

    Covered CPT Codes (when selection criteria met)CPTCovered
    96040Medical genetics and genetic counseling services, each 30 minutes face-to-face with patient/family
    Covered HCPCS Codes (when selection criteria met)HCPCSCovered
    S0265Genetic counseling, under physician supervision, each 15 minutes
    Related Lab CodesCPT
    82106Alpha-fetoprotein (AFP); amniotic fluid
    ICD-10 Codes (covered when selection criteria met)ICD-10Covered
    C18.0-C18.9Malignant neoplasm of colon
    D45Polycythemia vera
    D57.00-D57.819Sickle-cell disorders
    E28.39Other primary ovarian failure
    E28.8Other ovarian dysfunction
    E30.0-E30.1Delay in sexual development and puberty and precocious sexual development and puberty
    E75.02Tay-Sachs disease
    E84.0-E84.9Cystic fibrosis
    F70-F79Mental retardation
    F84.0Autistic disorder
    1–10 of 46
    1/5
    inv-10: Maternal age at delivery — >= 35 years
    Threshold>= 35 years at delivery
    ContextListed as one qualifying pregnancy-related indication for genetic counseling
    Actionable notePresence of maternal age >=35 alone meets the policy’s single-item medical necessity criterion for counseling
    inv-11: Repeated first trimester miscarriages — 3 or more (2 or more among infertile couples)
    ThresholdRepeated first-trimester miscarriages: 3 or more (2 or more among infertile couples)
    Context

    Provider Actions, Documentation, and Billing Guidance

    Prior Authorization

    Coverage tied to selection criteria (96040, S0265, related lab codes)

    CPT 96040 and HCPCS S0265 (and related listed lab codes such as 82106) are covered only when the policy's selection criteria for genetic counseling are met; coverage depends on meeting the medical necessity indications listed in this bulletin.

    • 96040 — Medical genetics and genetic counseling services, each 30 minutes face-to-face with patient/family (covered if selection criteria are met).
    • S0265 — Genetic counseling, under physician supervision, each 15 minutes (covered if selection criteria are met).
    • 82106 — Alpha-fetoprotein (AFP); amniotic fluid (related lab code listed).
    Prior Authorization

    Prior authorization determined by plan

    Prior authorization requirements are not set by this bulletin; participating providers must follow the member's plan benefit provisions and program rules to determine if prior authorization is required.

    • This Clinical Policy Bulletin is guidance to assist in administering plan benefits but does not define prior authorization—check the member's plan.

    Eligibility Requirements

    Eligibility for genetic counseling includes a documented family history indicating risk factors such as family history of primary malignant neoplasm, known carrier status (e.g., Z14.1, Z14.8, Z84.81), and family history of congenital malformations or other relevant disorders (e.g., Z82.71, Z82.79, Z84.3). Use the corresponding ICD-10 codes from the policy when submitting claims to demonstrate that the member meets the family-history–based eligibility criteria.

    Pre-test counseling should follow professional guidance and include documented informed consent that explains potential outcomes of testing, including carrier or disease-state findings and their implications for health, insurance, and reproductive decision-making. When counseling accompanies genetic testing, documentation of the counseling session and consent is expected in the medical record per ACMG/NSGC guidance.

    Not Covered Services

    Genetic counseling provided for indications other than those specifically listed in the medical necessity section is classified as experimental and investigational and is therefore not covered. This includes standalone counseling requests that are unrelated to the enumerated pregnancy indications or to medically necessary genetic testing consistent with ACMG guidelines.

    Definitions

    inv-21: Genetic counseling — definition
    DefinitionA process of communication between patients and trained professionals intended to provide information about genetic disease or risk, inheritance, management, and reproductive options to enable informed decisions.
    Counselor rolesEvaluate family medical problems/risks, analyze and explain inheritance patterns, provide management/treatment information, and discuss available options.
    Informed consentCounseling includes discussion that testing may reveal carrier or disease-state information affecting health, insurance, career, marriage, or reproductive options.

    Background

    Genetic counseling is a communication process between patients and trained professionals intended to provide information about genetic disease or risk, including inheritance, management, and reproductive options. Counseling should include discussion of implications for the individual and family and informed consent given the potential impact on health, insurance, and reproductive choices.

    Revision History

    1997-11-19effective_date

    Policy became effective.

    2023-03-28last_reviewLatest

    Policy last reviewed on 03/28/2023.

    2024-02-08next_review

    Next scheduled review date set for 02/08/2024.

    Policy Summary
    PayerAetna
    PolicyGenetic Counseling
    Policy CodePolicy 0189
    Change TypeNo material change
    Effective DateNov 19, 1997
    Last ReviewMar 28, 2023
    Next Review DateFeb 8, 2024
    Key ActionObtain informed consent and document counseling per ACMG guidance when genetic counseling accompanies testing.
    SourceLink
    On This Page
    Coverage Criteria for Genetic CounselingSpecific Indications and ScenariosBilling and Diagnosis CodesProvider Actions, Documentation, and Billing GuidanceEligibility RequirementsNot Covered ServicesDefinitionsBackgroundRevision History
    Genetic counseling provided in consideration of, or in conjunction with, medically necessary genetic testing and performed in accordance with ACMG guidelines.

    Counseling must be tied to medically necessary testing and follow ACMG guidance to be considered medically necessary.

    Listed as a pregnancy-related indication when there is suspicion of parental or fetal chromosome abnormalities
    Documentation implicationClinical suspicion of chromosomal abnormality should be noted to support medical necessity
  1. Prior authorization requirements are determined by the member's plan and program provisions.
  2. Step Therapy

    Step therapy — none specified

    No step therapy requirements are specified in this Clinical Policy Bulletin for genetic counseling services.

    • Providers should consult plan-specific provisions if unsure, but the bulletin itself lists no step therapy rules.
    Documentation Required

    Informed consent and counseling documentation

    Obtain informed consent and document counseling that the genetic test might reveal carrier status or disease-state information that could affect health, insurance, career, marriage, or reproductive options.

    • Documentation should reflect that the patient was informed of potential implications and the individual's right to accept or refuse testing per ACMG guidance.
    Documentation Required

    Policy and documentation note

    Policy history and review dates are maintained in the bulletin; providers should consult plan-specific Clinical Policy Bulletins and program provisions for details on documentation and benefit determinations.

    • Last review: 03/28/2023; Effective: 11/19/1997; Next review: 02/08/2024.
    • Clinical Policy Bulletins are guidance documents and do not constitute a contract—verify plan-specific requirements.
    Denial Risk

    Denial risk — experimental/investigational indications

    Genetic counseling for indications other than those listed in the medical necessity section is considered experimental and investigational and may be denied.

    • The bulletin states effectiveness for indications other than the listed ones has not been established, and such services are not covered.
    Denial Risk

    Coverage risk — subject to plan provisions

    Coverage is subject to the member's plan provisions and program terms; the Clinical Policy Bulletin is intended to assist administration of benefits but does not guarantee coverage.

    • Lack of adherence to plan provisions or program rules may result in denial of coverage.
    Note

    Pre-test informed consent and ACMG-consistent counseling

    Provide pre-test informed consent and counseling consistent with ACMG guidance, including discussion that testing may reveal carrier status or disease-state information and the implications for the individual's privacy, insurance, and reproductive options.

    • Counseling should evaluate family risks, explain inheritance patterns, and allow informed decision-making about testing per ACMG recommendations.
    Note

    Provider qualifications implied by counseling codes

    Procedure codes for genetic counseling (96040, S0265) reflect services typically provided by qualified professionals (e.g., medical geneticists or genetic counselors); the policy references professional guidance though it does not mandate specific provider credentialing in this section.

    • 96040 — Medical genetics and genetic counseling services, each 30 minutes face-to-face with patient/family.
    • S0265 — Genetic counseling, under physician supervision, each 15 minutes.
    Note

    Information — consult policy for details

    This bulletin provides policy guidance on genetic counseling indications, coding, and documentation; consult the bulletin and plan materials for specifics.

    • The document lists covered indications, exclusions, and related codes—use the bulletin and plan benefit descriptions to confirm applicability.